Similar articles for PMID: 18701101

Year	Number of Results
1990	1
1991	1
1992	1
1993	3
1994	1
1996	2
1997	3
1998	2
1999	1
2000	8
2001	5
2002	3
2003	3
2004	6
2005	6
2006	6
2007	6
2008	19
2009	17
2010	21
2011	20
2012	25
2013	21
2014	12
2015	21
2016	7
2017	10
2018	12
2019	7
2020	3
2021	5
2024	0

1

An increased serum progesterone-to-estradiol ratio on the day of human chorionic gonadotropin administration does not have a negative impact on clinical pregnancy rate in women with normal ovarian reserve treated with a long gonadotropin releasing hormone agonist protocol.

Lai TH, Lee FK, Lin TK, Horng SG, Chen SC, Chen YH, Wang PC. Lai TH, et al. Fertil Steril. 2009 Aug;92(2):508-14. doi: 10.1016/j.fertnstert.2008.06.036. Epub 2008 Aug 12. Fertil Steril. 2009. PMID: 18701101 Free article.

2

Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.

Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A. Schachter M, et al. Fertil Steril. 2008 Oct;90(4):1087-93. doi: 10.1016/j.fertnstert.2007.07.1316. Epub 2007 Nov 26. Fertil Steril. 2008. PMID: 18023439 Free article. Clinical Trial.

3

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles.

Wu Z, Li R, Ma Y, Deng B, Zhang X, Meng Y, Chen X, Liu P, Qiao J. Wu Z, et al. Reprod Biomed Online. 2012 May;24(5):511-20. doi: 10.1016/j.rbmo.2012.02.003. Epub 2012 Feb 14. Reprod Biomed Online. 2012. PMID: 22417667

4

[Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].

Yang S, Chen XN, Qiao J, Liu P, Li R, Chen GA, Ma CH. Yang S, et al. Zhonghua Fu Chan Ke Za Zhi. 2012 Apr;47(4):245-9. Zhonghua Fu Chan Ke Za Zhi. 2012. PMID: 22781108 Chinese.

5

Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.

Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS. Moon HS, et al. Fertil Steril. 2008 Dec;90(6):2172-8. doi: 10.1016/j.fertnstert.2007.10.033. Epub 2008 Apr 25. Fertil Steril. 2008. PMID: 18439601 Free article.

6

Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles.

Xu B, Li Z, Zhang H, Jin L, Li Y, Ai J, Zhu G. Xu B, et al. Fertil Steril. 2012 Jun;97(6):1321-7.e1-4. doi: 10.1016/j.fertnstert.2012.03.014. Epub 2012 Apr 10. Fertil Steril. 2012. PMID: 22494924 Free article.

7

Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?

Schoolcraft WB, Surrey ES, Minjarez DA, Stevens JM, Gardner DK. Schoolcraft WB, et al. Fertil Steril. 2008 Jan;89(1):151-6. doi: 10.1016/j.fertnstert.2007.02.013. Epub 2007 May 4. Fertil Steril. 2008. PMID: 17482177 Free article. Clinical Trial.

8

A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.

Propst AM, Bates GW, Robinson RD, Arthur NJ, Martin JE, Neal GS. Propst AM, et al. Fertil Steril. 2006 Jul;86(1):58-63. doi: 10.1016/j.fertnstert.2005.12.040. Epub 2006 Jun 6. Fertil Steril. 2006. PMID: 16753156 Clinical Trial.

9

Impact of endogenous luteinizing hormone serum levels on progesterone elevation on the day of human chorionic gonadotropin administration.

Hugues JN, Massé-Laroche E, Reboul-Marty J, Boîko O, Meynant C, Cédrin-Durnerin I. Hugues JN, et al. Fertil Steril. 2011 Sep;96(3):600-4. doi: 10.1016/j.fertnstert.2011.06.061. Fertil Steril. 2011. PMID: 21880277

10

A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.

Ku SY, Choi YS, Jee BC, Suh CS, Choi YM, Kim JG, Moon SY, Kim SH. Ku SY, et al. Gynecol Endocrinol. 2005 Oct;21(4):227-31. doi: 10.1080/09513590500282125. Gynecol Endocrinol. 2005. PMID: 16316845

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

212 results

Results by year